Search:
Computing and Library Services - delivering an inspiring information environment

Pharmacological treatment of depression in older people

Curran, Stephen, Byrne, Andrew and Wattis, John (2006) Pharmacological treatment of depression in older people. Mental Health and Learning Disabilities Research and Practice, 3 (1). pp. 63-85. ISSN 1743-6885

[img] PDF
Download (425kB)

Abstract

In the light of recent National Institute for Clinical Excellence (NICE) and Committee for the Safety of Medicines (CSM) guidance we discuss the importance of the diagnosis of depression in old age and review pharmacological interventions. An introductory section is followed by sections on each of the main antidepressant groups. This briefly describes their pharmacology and reviews research done specifically relevant to older people. Finally practical clinical applications are discussed.

▼ Jump to Download Statistics
Item Type: Article
Uncontrolled Keywords: pharmacological treatment; depression; older elderly people
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Schools: School of Human and Health Sciences
School of Human and Health Sciences > Ageing and Mental Health Research Group
Related URLs:
References: Abou-Saleh, M.T. & Coppen A. 1983. The prognosis of depression in old age: the case for lithium therapy. British Journal of Psychiatry,; 170, 285- 287. Aguglia, E. 2000. Reboxetine in the maintenance therapy of depressive disorder in the elderly: a long-term open study International Journal of Geriatric Psychiatry, 15, 784-93.. Akiskal, H.S. 1985. An approach to chronic and ‘resistant’ depressions: evaluation and treatment. Journal of Clinical Psychiatry,; 46, 32-36. Alexopoulous, G.S. 1992. Geriatric depression reaches maturity. International Journal of Geriatric Psychiatry, 7, 305-306. Ames, D., Ashby, D., Mann, A.H. & Graham, N. 1988. Psychiatric illness in elderly residents of part 3 homes in one London borough: prognosis and review. Age and Ageing, 17(4), 249-256. Anderson, I. & Edwards, J. 2001. Guidelines for choice of selective serotonin reuptake inhibitor in depressive illness. Advances in Psychiatric Treatment,, 7, 170-180. Anderson, I.M., Nutt, D.J., & Deakin, J.F.W. 2000. Evidence-based guidelines for treating depressive disorders with antidepressants; a revision of the 1993 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology, 14(1), 3-20. Anderson, I.M. 2001. Meta-analytical studies on new antidepressants. British Medical Bulletin, 1, 161-178. Angst, J. 1997. A regular review of long term follow-up of depression. British Medical Journal, 315, 1143-1146. Appelberg, B. 2002. Long-term citalopram prevents recurrent depression in the elderly and is well tolerated. Evidence Based Mental Health, 6(1):24. Ariyo, A.A., Haan, M., Tangen, C.M. et al. 2000. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation, 102, 1773-1779. Aronson, R., Offman, H.J., Joffe R.T. & Naylor, C.D. 1996. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Archives of General Psychiatry, 53, 842-848. Austin, M.P.V., Souza, F.G.M. & Goodwin, G.M. 1991. Lithium augmentation in antidepressant-resistant patients: a quantitative analysis. British Journal of Psychiatry,159, 510-14. Baldwin, R.C. 1996. Treatment resistant depression in the elderly: a review of treatment options. Reviews in Clinical Gerontology, 6, 343-348.Baldwin, R.C., Chiu, E, Katona, C, & Grahaam, N. 2002. Guidelines on Depression in Older People: practising the evidence. Martin Dunitz, London. Barak, Y., Swartz, M., Levy, D. et al. 2003. Age-related differences in the side-effect profile of citalopram. Progress in Neuropsychopharmacology and Biological Psychiatry, 27(3), 545-548. Barbui, C. & Hotopf, M. 2001. Amitriptyline versus the rest; still the leading antidepressant after 40 years of randomised controlled trials. British Journal of Psychiatry, 178, 129-144. Baumann, P. 1998. Care of depression in the elderly: comparative pharmacokinetics of SSRIs. International Clinical Psychopharmacology, 13 (suppl.5), 35-43. N. F. N. Bergmann, J.F., Laneury, J.P., Duchene, P., Fleishaker, J.C., Houin, G & Segrestaa, J.M. 2000. Pharmacokinetics of reboxetine in healthy, elderly volunteers. European Journal of Drug Metabolism & Pharmacokinetics, 25(3-4), 195-198. Bielski, R., Ventura, D. & Chung-Chi C. 2003. A double-blind comparison of escitalopram with venlafaxine XR in the treatment of major depressive disorder. 16th Congress of the European College of Neuropsychopharmacology, Prague, 20-24, September 2003. Bodani, M. Sheehan, B. & Philpot M. 1999. The use of dexamethasone in elderly patients with antidepressant–resistant depressive illness. Journal of Psychopharmacology, 13(2), 196-197. Bonnet, U. 2003. Moclobemide; therapeutic use and clinical studies. CNS Drug Reviews, 9(1), 97-140. Bowskill, R.J. & Bridges, P.L. 1997. Treatment-resistant affective disorders. British Journal of Hospital Medicine, 57, 171-172. Committee on Safety of Medicines 2004. Report of the CSM Expert Working Group on the Safety of Selective Serotonin reuptake Inhibitors Antidepressants, December 2004, www.mhra.gov.uk Committee on Safety of Medicines 2004. Safety of Selective Serotonin Reuptake Inhibitor Antidepressants. www.mhra.gov.uk Cowen, P.J. 1998. Pharmacological management of treatment-resistant depression. Advances in Psychiatric Treatment,,4, 320-327. Cujpers, P. 1998. Psychological outreach programmes for the depressed elderly: A meta-analysis of effects and dropout. International Journal of Geriatric Psychiatry, 13(1), 41-48. Curran, S. 1995. Effect of paroxetine on seizure length during electroconvulsive therapy. Acta Psychiatrica Scandinavica, 12(2), 239-240.Curran, S. & Wattis, J.P. 2004. Psychopharmacology in the elderly. In: Seminars in Clinical Psychopharmacology (Ed. D.J King), 2nd Edition, Gaskell, London, 447-484. Curran, S, Nightingale, S. & Wattis, J.P. 2005. Practical issues in assessing and prescribing psychotropic drugs in older people. In: Practical Old Age Psychopharmacology; A Multi-Professional Approach, S Curran and R Bullock (Eds.), Radcliffe Medical, Oxford, 47-72. Danjou, P. & Hackett D. 1995. Safety and tolerance profile of venlafaxine. International Clinical Psychopharmacology,, 10 (Suppl.2), 15-20. Donoghue, J. & Hylan, T.R. 2001. Antidepressant use in clinical practice; efficacy versus effectiveness. British Journal of Psychiatry, 179 (Suppl.42), 9-17. Dwyer, M. & Byrne, G.J. 2000. Disruptive vocalisation and depression in older nursing home residents. International Psycho geriatrics, 12, 463-471. Einarson, T.R., Arikian, S.R,. Casciano, J. & Doyle, J.J. 1999. Comparison of extended release Venlafaxine, selective serotonin re-uptake inhibitors, and tricyclic antidepressants in the treatment of depression: a metaanalysis of randomised controlled trials. Clinical Therapeutics, 21, 296-308. Emptage, R.E., Semla, T.P., Gonzales, L. & Larouche, M. 1996. Depression in the medically ill elderly: A focus on methylphenidate. Annals of Pharmacotherapy, 30(2), 151-157. Everybody's Business. Integrated mental health service for older adults: a service development guide 2005. Care Services Improvement Partnership/ Department of Health, London: www.everybodysbusiness.org.uk. Fahy, S. & Lawlor BA. 2001. Discontinuation of lithium augmentation in an elderly cohort. International Journal of Geriatric Psychiatry, 16(10), 1004- 1009. Flint, A.J. 2002. Treatment-resistant depression in late life. CNS Spectrums, 7(10), 733-738. Flint, A.J. & Rifat, S.L. 1996. The effect of sequential antidepressant treatment on geriatric depression. Journal of Affective Disorders, 36, 95- 105. Flint, A J. 1992. The optimum duration of antidepressant treatment in the elderly. International Journal of Geriatric Psychiatry, 7, 617-619. Flint, A.J., Rifat, S.L. 1994. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. Journal of Clinical Psychopharmacology, 14, 353-356. Furukawa, T., McGuire, H. & Barbui C 2004. Low dosage tricyclic antidepressants for depression. Cochrane Review 3,.Georgotas, A. & McCue, R. 1989. The additional benefit of extending an antidepressant trial past seven weeks in the depressed elderly. International Journal of Geriatric Psychiatry, 4, 191-195. Georgotas, A.M.R., Cooper, T. 1989. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine. Psychiatry Research, 28, 1-9. Glassman, A.H., O’Connor, C.M., Califf, R.M., Swedberg, K. et al. 2002. Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288(6), 701- 709. Guaiana, G., Barbui, C. & Hotopf, M. 2004. Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Review 3. Guscott, R. & Grof. P. 1991. The clinical meaning of refractory depression: a review for the clinician. American Journal of Psychiatry, 148, 695-704. Hale, A, Proctor, A.W. & Bridges, P.K. 1987. Clomipramine, tryptophan and lithium in combination for resistant endogenous depression seven case studies. British Journal of Psychiatry, 151, 213-217. Halikas, J.A. 1995. Org 3770 (mirtazapine) versus trazodone; a placebo controlled trial in depressed elderly patients. Human Psychopharmacology,; 10, 125-133. Hindmarch, I. 2001. Expanding the horizons of depression; beyond the monoamine hypothesis. Human Psychopharmacology, 16(3), 203-218. Hoencamp, E., Haffmans, P.M.J., Dijken, W.A., et al. 2000. Lithium augmentation of venlafaxine: an open-label trial. Journal of Clinical Psychopharmacology, 20, 538-543. Hoyberg, O.J., Maragakis, B., & Mullin, J. et al. 1996. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psychiatrica Scandinavica, 93, 184-190. Hudson, J.I., Wohlreich, M.M., Kajdasz, D.K. et al. 2005. Safety and tolerability of duloxetine in the treatment of major depressive disorder; an analysis of pooled data from eight placebo-controlled clinical trials. Human Psychopharmacology, 20, 327-341. Jonas, B.S. & Mussolino, M. E. 2000. Symptoms of depression as a prospective risk factor for stroke. Psychosomatic Medicine, 62, 463-471. Kalayam, B. & Alexopoulos, G.S. 1999. Prefrontal dysfunction and treatment response in geriatric depression. Archives of General Psychiatry, 56(8), 713-718. Katona, C., Bercoff, E., Chiu, E., Tack, P., Versiani, M. & Woelk, H. 1999. Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders; a double-blind randomised trial. Journal of Affective Disorders, 55, 203-213.Kirby, D., Harrigun, S. & Ames, D. 2002. Hyponatraemia in elderly psychiatric patients treated with SSRIs and venlafaxine: a retrospective controlled study in an in-patient unit. International Journal of Geriatric Psychiatry,; 17, 231-7. Koenig, H.G., Meador, K. G., Cohen, H.J. & Blazer, D. 1988. Depression in elderly hospitalised patients with medical illness. Archives of Internal Medicine, 148, 1929-1936. Krystal, A.D., Coffey, C.E., Weiner, R.D. & Holsinger, T. 1998. Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings. Journal of Neuropsychiatry & Clinical Neurosciences, 10(2), 178-186. Laidlaw, K, Thompson, L.W., Dick-Siskin, L. & Gallagher-Thompson, D. 2003. Cognitive Behaviour Therapy with Old People. John Wiley & Sons, Chichester Li, Y.S., Meyer, J.S. & Thornby, J. 2001. Longitudinal follow-up of depressive symptoms among normal versus cognitively impaired elderly. International Journal of Geriatric Psychiatry, 16(7), 718-727. Mahapatra, S.N. & Hackett, D. 1997. A randomised, double-blind, parallelgroup comparison of venlafaxine and dothiepin in geriatric patients with major depression. International Journal of Clinical Practice, 51(4). 209-213. Mendlewicz, J. 1995. Pharmacologic profile and efficacy of venlafaxine. International Clinical Psychopharmacology, 10 (Suppl.2), 5-13. Mendlewicz, J. 2001. Optimising antidepressant use in clinical practice; towards criteria for antidepressant selection. British Journal of Psychiatry, 179 (Suppl. 42), 1-3. Mittman, N., Herrmann, N., Einarson, T.R. et al. 1997. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. Journal of Affective Disorders, 46, 191-217. Moreno, F.A., Gelenberg, A.J., Bachar, K. & Delgado, P.L. 1997. Pindolol augmentation of treatment-resistant depressed patients. Journal of Clinical Psychiatry, 58(10), 437-439. Morishita, S., Aoki, S. 1999. Clonazepam in the treatment of prolonged depression. Journal of Affective Disorders, 53(3), 275-278. Mottram, P, Wilson, K.C.M., Ashworth, L. & Abou-Saleh, M. 2002. The clinical profile of older patients' response to antidepressants - an open trial of sertraline. International Journal of Geriatric Psychiatry, 17, 574-578. Navarro, V., Gasto, C., Torres, .X, Marcos, T. & Pintos, L. 2001. Citalopram versus nortriptyline in late-life depression: A 12 week randomized singleblind study. Acta Psychiatrica Scandinavica, 103(6), 435-440. National Institute for Clinical Excellence 2004. Depression: Management of Depression in Primary and Secondary Care, Clinical Guideline 23, December, London.Nelson, J.C., Wohlreich, M.M., Mallinckrodt, C.H. et al. 2005. Duloxetine for the treatment of major depressive disorder in older people. American Journal of Geriatric Psychiatry, 13(3), 227-235. Nierenberg, A.A., Feighner, J.P., Rudolph, R. et al. 1994. Venlafaxine for treatment-resistant unipolar depression. Journal of Clinical Psychopharmacology, 14, 419-423. 2000. Neuroimaging in dementia and Old Age Depression Interest Group 1993. How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry, 162, 75-182. Oslin, D.W., Have, T.R.T. & Streim, J.E. et al.2003. Probing the safety of medications in the frail elderly; evidence from a randomised clinical trial of sertraline and venlafaxine in depressed nursing home residents. Journal of Clinical Psychiatry, 64(8), 875-882. Penninx, B.W., Deeg, D.J., van Eijk, J.T. et al. 2000. Changes in depression and physical decline in older adults; a longitudinal perspective. Journal of Affective Disorders, 61, 1-12. Pridmore, S. & Turnier, S.Y. 2004. Medication options in the treatment of treatment-resistant depression. Australian and New Zealand Journal of Psychiatry, 38(4), 219-225. Rapaport,M.H., Schneider, L.S., Dunner, D.L. et al. 2003. Efficacy of controlled-release paroxetine in the treatment of late-life depression. Journal of Clinical Psychiatry, 64(9), 1065-1074. Renwick, R.A. 1985. Treatment resistant depression. Psychiatric Journal of University of Ottawa, 46, 576-584. Reynolds, C.F., III, Perel, J.M. & Frank E, et al. 1999. Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levels. American Journal of Psychiatry, 156(8), 1177-1181. Roth, M., Montjoy, C. & Amrein, R. 1996. Moclobemide in elderly patients with cognitive decline and depression: an international double–blind trial, placebo-controlled trial. British Journal of Psychiatry, 168(2), 149-157. Schatzberg, A.F., Kremer, C., Rodrigues, H.E., Murphy & G.M. et al. 2002. Double-blind, randomised comparison of mirtazapine and paroxetine in elderly depressed patients. American Journal of Geriatric Psychiatry, 10(5), 541-550. Shapira, B., Tub,i N., Drexler, H., Lidsky, D., Calev, A. & Lerer, B. 1998. Cost and benefit in the choice of ECT schedule. Twice versus three times weekly ECT. British Journal of Psychiatry, 172, 44-48.Sheikh, J..I, Cassidy, E.L., Doraiswamy, P.M. et al. 2004. Efficacy, safety and tolerability of sertraline in patients with late-life depression. Journal of the American Geriatrics Society, 52(1). 86-92. Smith, D., Dempster, C., Glanvile, J. et al. 2002. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants; a meta-analysis. British Journal of Psychiatry, 180, 396- 404. Stah,l S. & Briley, M. 2004. Understanding pain in depression. Human Psychopharmacology, 19, S9-S13. Stahl, S 2000. Essential Psychopharmacology; Neuroscientific Basis and Practical Applications. Second Edition, Cambridge, CUP. Stahl, S.M. 1998. Basic psychopharmacology of antidepressants part 2: oestrogen as an adjunct to antidepressant treatment. Journal of Clinical Psychiatry, 59(4), 15-24. Thase, M.E. & Rush, A.J. 1997. Treatment resistant depression. In: Bloom FEaKD, editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, 1081-1215. Thase, M.E., Entsuah, R. & Rudolph, R.L. 2001. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. British Journal of Psychiatry, 178, 234-241. Timmer, .CL., Paanakker, J.E. & van Hal, H.J.M. 1996. Pharmacokinetics of mirtazapine from orally administered tablets: influence of age, gender and treatment regimen. Human Psychopharmacology, 11, 497-509. Tourigny-Rivard, M.F. 1997. Pharmacotherapy of affective disorders in old age. Canadian Journal of Psychiatry, 42 (1)
Depositing User: Sara Taylor
Date Deposited: 17 Apr 2008 14:02
Last Modified: 31 Mar 2018 13:46
URI: http://eprints.hud.ac.uk/id/eprint/665

Downloads

Downloads per month over past year

Repository Staff Only: item control page

View Item View Item

University of Huddersfield, Queensgate, Huddersfield, HD1 3DH Copyright and Disclaimer All rights reserved ©